These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 26327491)

  • 1. Competing risk bias in Kaplan-Meier risk estimates can be corrected.
    van Walraven C; Hawken S
    J Clin Epidemiol; 2016 Feb; 70():101-5. PubMed ID: 26327491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Competing risk bias was common in Kaplan-Meier risk estimates published in prominent medical journals.
    van Walraven C; McAlister FA
    J Clin Epidemiol; 2016 Jan; 69():170-3.e8. PubMed ID: 26232083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of competing risks analysis improved prognostic assessment of patients with decompensated chronic heart failure and reduced left ventricular ejection fraction.
    Scrutinio D; Guida P; Passantino A; Ammirati E; Oliva F; Lagioia R; Frigerio M
    J Clin Epidemiol; 2018 Nov; 103():31-39. PubMed ID: 30009940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kaplan-Meier Survival Analysis Overestimates the Risk of Revision Arthroplasty: A Meta-analysis.
    Lacny S; Wilson T; Clement F; Roberts DJ; Faris PD; Ghali WA; Marshall DA
    Clin Orthop Relat Res; 2015 Nov; 473(11):3431-42. PubMed ID: 25804881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ignoring competing events in the analysis of survival data may lead to biased results: a nonmathematical illustration of competing risk analysis.
    Schuster NA; Hoogendijk EO; Kok AAL; Twisk JWR; Heymans MW
    J Clin Epidemiol; 2020 Jun; 122():42-48. PubMed ID: 32165133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kaplan-Meier survival analysis overestimates cumulative incidence of health-related events in competing risk settings: a meta-analysis.
    Lacny S; Wilson T; Clement F; Roberts DJ; Faris P; Ghali WA; Marshall DA
    J Clin Epidemiol; 2018 Jan; 93():25-35. PubMed ID: 29045808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluating health outcomes in the presence of competing risks: a review of statistical methods and clinical applications.
    Varadhan R; Weiss CO; Segal JB; Wu AW; Scharfstein D; Boyd C
    Med Care; 2010 Jun; 48(6 Suppl):S96-105. PubMed ID: 20473207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Introduction to the Analysis of Survival Data in the Presence of Competing Risks.
    Austin PC; Lee DS; Fine JP
    Circulation; 2016 Feb; 133(6):601-9. PubMed ID: 26858290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Competing time-to-event endpoints in cardiology trials: a simulation study to illustrate the importance of an adequate statistical analysis.
    Rauch G; Kieser M; Ulrich S; Doherty P; Rauch B; Schneider S; Riemer T; Senges J
    Eur J Prev Cardiol; 2014 Jan; 21(1):74-80. PubMed ID: 22964966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of the Cox model to the Fine-Gray model for survival analyses of re-fracture rates.
    Nolan EK; Chen HY
    Arch Osteoporos; 2020 Jun; 15(1):86. PubMed ID: 32519193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modelling competing risks in nephrology research: an example in peritoneal dialysis.
    Teixeira L; Rodrigues A; Carvalho MJ; Cabrita A; Mendonça D
    BMC Nephrol; 2013 May; 14():110. PubMed ID: 23705871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cumulative incidence in competing risks data and competing risks regression analysis.
    Kim HT
    Clin Cancer Res; 2007 Jan; 13(2 Pt 1):559-65. PubMed ID: 17255278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Competing Risk of Death When Comparing Tibial Implant Types in Total Knee Arthroplasty.
    Maradit Kremers H; Kremers WK; Sierra RJ; Lewallen DG; Berry DJ
    J Bone Joint Surg Am; 2016 Apr; 98(7):591-6. PubMed ID: 27053588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overestimation of prostate cancer mortality and other-cause mortality by the Kaplan-Meier method.
    Zhu X; Kranse R; Bul M; Bangma CH; Schröder FH; Roobol MJ
    Can J Urol; 2013 Jun; 20(3):6756-60. PubMed ID: 23783043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The analysis of competing events like cause-specific mortality--beware of the Kaplan-Meier method.
    Verduijn M; Grootendorst DC; Dekker FW; Jager KJ; le Cessie S
    Nephrol Dial Transplant; 2011 Jan; 26(1):56-61. PubMed ID: 21059831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. On the choice of timescale for other cause mortality in a competing risk setting using flexible parametric survival models.
    Skourlis N; Crowther MJ; Andersson TM; Lambert PC
    Biom J; 2022 Oct; 64(7):1161-1177. PubMed ID: 35708221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A note on competing risks in survival data analysis.
    Satagopan JM; Ben-Porat L; Berwick M; Robson M; Kutler D; Auerbach AD
    Br J Cancer; 2004 Oct; 91(7):1229-35. PubMed ID: 15305188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are competing risks models appropriate to describe implant failure?
    Sayers A; Evans JT; Whitehouse MR; Blom AW
    Acta Orthop; 2018 Jun; 89(3):256-258. PubMed ID: 29521152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cumulative incidence rate of medical consultation for fecundity problems--analysis of a prevalent cohort using competing risks.
    Duron S; Slama R; Ducot B; Bohet A; Sørensen DN; Keiding N; Moreau C; Bouyer J
    Hum Reprod; 2013 Oct; 28(10):2872-9. PubMed ID: 23838160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival analysis in total joint replacement: an alternative method of accounting for the presence of competing risk.
    Fennema P; Lubsen J
    J Bone Joint Surg Br; 2010 May; 92(5):701-6. PubMed ID: 20436009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.